The U.S. biomedical research enterprise contributes significantly to the nation’s health and economy. An author group conducted a thorough review to determine whether the enterprise can continue to lead globally and address our population’s health needs in the face of complex challenges. This report presents the results of that review and lays out priorities to reimagine and reinvigorate the biomedical research enterprise before a moment of crisis. In this webinar hosted by NAM President Victor J. Dzau, a panel of author group members presented an overview of the report followed by a discussion with national leaders in biomedical research.

Agenda:

Welcome:

• Victor J. Dzau, National Academy of Medicine

Overview of Report Findings:

• E. Albert Reece (Author Group Chair), University of Maryland School of Medicine
• Ann Kurth, The New York Academy of Medicine
• Sudip Parikh, American Association for the Advancement of Science
• Elias Zerhouni, Johns Hopkins University

Discussion with National Leaders in Biomedical Research:

• Victor J. Dzau (Moderator), National Academy of Medicine
• Monica Bertagnolli, National Institutes of Health
• Kimryn Rathmell, National Cancer Institute
• John Reed, Johnson & Johnson
• Robert Conn, University of California, San Diego